Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockade
Nicolas Jacquelot, Takahiro Yamazaki, María P. Roberti, et al.
Cell Research (2019) Vol. 29, Iss. 10, pp. 846-861
Open Access | Times Cited: 205

Showing 1-25 of 205 citing articles:

Moving towards personalized treatments of immune-related adverse events
Khashayar Esfahani, Arielle Elkrief, Cassandra Calabrese, et al.
Nature Reviews Clinical Oncology (2020) Vol. 17, Iss. 8, pp. 504-515
Closed Access | Times Cited: 248
Signal pathways of melanoma and targeted therapy
Weinan Guo, Huina Wang, Chunying Li
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 225
Prolonged activation of innate immune pathways by a polyvalent STING agonist
Suxin Li, Min Luo, Zhaohui Wang, et al.
Nature Biomedical Engineering (2021) Vol. 5, Iss. 5, pp. 455-466
Open Access | Times Cited: 222
Type I interferon-mediated tumor immunity and its role in immunotherapy
Renren Yu, Bo Zhu, Degao Chen
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 3
Open Access | Times Cited: 188
Targeting the gut microbiota for cancer therapy
Miriam R. Fernandes, Poonam Aggarwal, Raquel Costa, et al.
Nature reviews. Cancer (2022) Vol. 22, Iss. 12, pp. 703-722
Closed Access | Times Cited: 149
The Impact of Radiation-Induced DNA Damage on cGAS-STING-Mediated Immune Responses to Cancer
Quinn Storozynsky, Mary Hitt
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 22, pp. 8877-8877
Open Access | Times Cited: 148
Myeloid cell-targeted therapies for solid tumours
Sangeeta Goswami, Swetha Anandhan, Deblina Raychaudhuri, et al.
Nature reviews. Immunology (2022) Vol. 23, Iss. 2, pp. 106-120
Closed Access | Times Cited: 144
In vivo CRISPR screens identify the E3 ligase Cop1 as a modulator of macrophage infiltration and cancer immunotherapy target
Xiaoqing Wang, Collin Tokheim, Shengqing Gu, et al.
Cell (2021) Vol. 184, Iss. 21, pp. 5357-5374.e22
Open Access | Times Cited: 134
The immunostimulatory RNA RN7SL1 enables CAR-T cells to enhance autonomous and endogenous immune function
Lexus R. Johnson, Daniel Y. Lee, Jacqueline S. Eacret, et al.
Cell (2021) Vol. 184, Iss. 19, pp. 4981-4995.e14
Open Access | Times Cited: 127
In vivo CRISPR screens reveal the landscape of immune evasion pathways across cancer
Juan Dubrot, Peter P. Du, Sarah Kate Lane-Reticker, et al.
Nature Immunology (2022) Vol. 23, Iss. 10, pp. 1495-1506
Closed Access | Times Cited: 124
Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B
Martina Musella, Andrea Guarracino, Nicoletta Manduca, et al.
Nature Immunology (2022) Vol. 23, Iss. 9, pp. 1379-1392
Open Access | Times Cited: 78
Cancer cells resistant to immune checkpoint blockade acquire interferon-associated epigenetic memory to sustain T cell dysfunction
Jingya Qiu, Bihui Xu, Darwin Ye, et al.
Nature Cancer (2023)
Closed Access | Times Cited: 61
Targeting cytokine and chemokine signaling pathways for cancer therapy
Ming Yi, Tianye Li, Mengke Niu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 50
Type I interferon and cancer
Peter Holíček, Emma Guilbaud, Vanessa Klapp, et al.
Immunological Reviews (2023) Vol. 321, Iss. 1, pp. 115-127
Open Access | Times Cited: 43
Opposing Roles of Type I Interferons in Cancer Immunity
Giselle M. Boukhaled, Shane M. Harding, David G. Brooks
Annual Review of Pathology Mechanisms of Disease (2020) Vol. 16, Iss. 1, pp. 167-198
Open Access | Times Cited: 135
The immuno-oncological challenge of COVID-19
Lisa Derosa, Cléa Melenotte, Frank Griscelli, et al.
Nature Cancer (2020) Vol. 1, Iss. 10, pp. 946-964
Open Access | Times Cited: 117
Combinational Immunotherapy for Hepatocellular Carcinoma: Radiotherapy, Immune Checkpoint Blockade and Beyond
Yun Hua Lee, David Tai, Connie Yip, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 116
A Randomized Phase 2 Study of Pembrolizumab With or Without Radiation in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma
Umair Mahmood, Andrew Bang, Yu‐Hui Chen, et al.
International Journal of Radiation Oncology*Biology*Physics (2020) Vol. 109, Iss. 1, pp. 134-144
Open Access | Times Cited: 93
Inherited PD-1 deficiency underlies tuberculosis and autoimmunity in a child
Masato Ogishi, Rui Yang, Caner Aytekin, et al.
Nature Medicine (2021) Vol. 27, Iss. 9, pp. 1646-1654
Open Access | Times Cited: 86
NF-κB and Its Role in Checkpoint Control
Annika Betzler, Marie‐Nicole Theodoraki, Patrick J. Schuler, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 11, pp. 3949-3949
Open Access | Times Cited: 73
Epigenetic Mechanisms of Resistance to Immune Checkpoint Inhibitors
Alexandre Perrier, Audrey Didelot, Pierre Laurent‐Puig, et al.
Biomolecules (2020) Vol. 10, Iss. 7, pp. 1061-1061
Open Access | Times Cited: 73
Activation of NF-κB and p300/CBP potentiates cancer chemoimmunotherapy through induction of MHC-I antigen presentation
Yixuan Zhou, Ingmar N. Bastian, Mark D. Long, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 8
Open Access | Times Cited: 73
Turning tumors from cold to inflamed to improve immunotherapy response
Camille L. Gérard, Julie Delyon, Alexandre Wicky, et al.
Cancer Treatment Reviews (2021) Vol. 101, pp. 102227-102227
Closed Access | Times Cited: 71
Maximizing response to intratumoral immunotherapy in mice by tuning local retention
Noor Momin, Joseph R. Palmeri, Emi A. Lutz, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 60
Acquired Resistance to Immune Checkpoint Blockades: The Underlying Mechanisms and Potential Strategies
Binghan Zhou, Yuan Gao, Peng Zhang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 58
Page 1 - Next Page

Scroll to top